A purity figure is usually the first number a research group sees and the last one it interrogates. It arrives on a product page, in a quotation email or in a catalogue entry, and it looks decisive: ≥99%, 99.1%, 98.5%. Before an in-vitro assay is booked — plates ordered, diluent prepared, bench time reserved — that percentage deserves a more careful reading. It is a useful, honest and genuinely informative measurement. It is also a narrow one, generated by a specific method, on a specific sample, at a specific moment. Understanding its boundaries is what separates a well-planned experiment from an expensive lesson in analytical assumptions.
What an HPLC Purity Percentage Actually Measures
High-performance liquid chromatography separates the components of a sample and reports them as peaks. The purity figure quoted for a research peptide is, in almost every case, an area percentage: the area of the peak assigned to the target compound, divided by the total area of all integrated peaks, multiplied by one hundred. It is a ratio of detector response, not a declaration of mass, molarity or suitability for a given assay. That distinction matters more than it first appears.
The number therefore belongs to the method that produced it. A different column, a different gradient, a different detection wavelength or a different integration threshold can shift a result by tenths of a percent without anything changing inside the vial. A figure of 99% is not a universal property of a molecule; it is a property of a molecule as observed under a defined set of conditions, and those conditions should be visible on the certificate that accompanies the batch.
Detection limits shape the figure too. Components that do not absorb in the monitored UV region, or that elute beneath the target peak, contribute nothing to the impurity side of the equation. Closely related species may be present and simply unresolved. The chromatogram is a snapshot of what the method can see, and a routine purity check is not the same as an impurity-hunting study.
Most importantly, area percentage is not mass percentage. Water content, residual solvents, counter-ions and any excipients present in the vial are largely invisible to the calculation, yet they all contribute to what is actually in the tube when the assay begins. A material reading ≥99% by area can be meaningfully less than 99% target peptide by mass — and that gap feeds directly into how a stock solution is prepared and how a concentration–response curve behaves.
What the Figure Leaves Unanswered: Identity, Salts and the Impurity Profile
Two peptides differing by a single amino acid, an acetyl group or an epimerised residue may behave almost identically on a reversed-phase column. A purity figure describes how much of the target is present; it does not confirm that the target is what it is claimed to be. Identity is established by a separate technique, most commonly mass spectrometry alongside the chromatographic method, and the certificate should demonstrate both. Research Sciences describes every compound as accompanied by an HPLC CoA covering purity and identity, with full-spectrum testing described as evaluating purity, identity, heavy metals and endotoxin. Those are the supplier’s published descriptions; the document that matters is the one issued for the specific batch, and it should be read line by line rather than summarised by its headline number. Where the homepage lists “CoAs Janoshik Analytical Reports”, the researcher should still open and check the CoA that accompanies the material in hand.
Peptides are frequently supplied as salts, carrying trifluoroacetate or acetate counter-ions through from purification. These influence mass, solubility and the ionic environment of an in-vitro system, and they do not appear as peaks on a standard purity chromatogram. The same applies to the trace mannitol that Research Sciences states is present in its peptides as an excipient — added for stability during lyophilisation, to aid solubility and to protect the material in storage. None of this represents a defect; it is simply chemistry sitting outside the scope of a percentage, and it should be accounted for when calculating concentration for a laboratory workflow.
The complement of the purity figure — the remaining one percent — is often more informative than the headline itself. What sits inside it? Truncated sequences from incomplete coupling, oxidised species, diastereomers, residual protecting groups and, invariably, water. A certificate that lists the significant related substances gives a research group something to reason with; a single number does not. Heavy metals and endotoxin fall entirely outside the HPLC window and require their own assays, which Research Sciences describes as part of an expanded testing framework. Confirm on the batch CoA whether such screening was performed for the material actually supplied, rather than assuming it from a category page.
From Certificate to Bench: What to Confirm Before Booking the Assay
The practical starting point is batch traceability. Vial labels use a reference format combining the SKU code and expiry date — for example, BPC10-03/27 — which links to the corresponding CoA. Quote that reference when contacting the supplier about documentation. Note also the site’s own caveat on restocks: a restocked product may carry the same Internal Test Reference as earlier stock, and an ITR links to associated sample testing reports without confirming that separate deliveries originate from the same production lot or have been independently tested again. Cap colours and other packaging details may vary and are not indicators of identity, analytical quality or manufacturing origin.
For groups ordering from a domestic catalogue — the Uk peptides range published by Research Sciences, for instance — the batch CoA rather than the product-page headline should drive the decision. Published figures such as “≥99% Verified Purity”, “UK Research Materials Over 99.1% Purity”, “3,000+ UK Orders”, “24hr UK Delivery” and “7 Days Expert Customer Support” reflect the shop’s current wording on its live pages and should be reconfirmed there before any order is placed, along with the exact purity stated on the CoA for the batch concerned.
Storage history matters as much as release purity. Lyophilised material should be held at −20°C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided. Reconstituted peptide is less stable and should be kept at 2–8°C for short-term laboratory use only. In an in-vitro context, record diluent volume and resulting concentration clearly, and treat any reconstitution calculator as a laboratory aid for assay planning — it is not intended for, and must not be used for, human or veterinary dosing. Research Sciences states that its materials are supplied strictly for controlled laboratory and analytical research, are labelled “For Research Use Only – Not for Human Consumption”, and are not medicines, medical devices, injectables, treatments or food supplements under UK law. They are not for human or veterinary use, and the purchaser remains responsible for lawful use, safe handling, storage and disposal, including compliance with COSHH and laboratory safety standards.
Fulfilment details are similarly worth verifying at checkout rather than assuming: orders are described as dispatched the next working day via Royal Mail Tracked 24, with delivery times given as estimates, and returns are not accepted once dispatched except for damage, incorrect supply or quality issues under the Refunds & Returns Policy. A purity figure can open the conversation about a new assay; only the batch documentation, the identity data and the handling record behind it can close it responsibly.
